President Donald Trump’s White House says Trump’s blueprint to bringing down the cost of prescription drugs would produce stronger results than plans put forth by Democrats, the New York Times reports.
Trump in his drug pricing speech Friday walked back two proposal he endorsed during the 2016 presidential campaign, however — proposals Democrats have long supported.
Democrats say the government should directly enter into negotiations with drugmakers to reduce costs for Medicare beneficiaries, and that consumers should have the ability to import drugs from other developed countries where brand drugs can carry an easier-to-swallow price tag.
Health and Human Services Secretary Alex Azar in a speech Monday made clear the administration’s position.
“The only way that direct negotiation could possibly save money is by doing something this administration doesn’t believe in: denying access to certain medicines for all Medicare beneficiaries through rationing, or setting prices for drugs by government fiat,” Azar said. “We don’t believe either of these proposals would put American patients first. They would move us toward the kind of socialized medicine systems that have such a notorious reputation for poor quality and access.”
To read the full report on the New York Times, click here.